| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | I5HF2X04PB |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| BINDING AGENT | T-cell surface glycoprotein CD3 epsilon chain binding agent | PubMed |
| Primary Target | |
|---|---|
| CD3e |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Diabetes Mellitus, Type 1 | 3 | D003922 | ClinicalTrials |
| Graves Ophthalmopathy | 2 | D049970 | ClinicalTrials |
| Arthritis, Rheumatoid | 1 | D001172 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 881191-44-2 |
| ChEMBL | CHEMBL1743053 |
| FDA SRS | I5HF2X04PB |
| Guide to Pharmacology | 8458 |
CONTENTS